On the molecular level, elevated TF and consecutive thrombin activation lead to several cancer-progression mechanisms via the protease-activated receptor (PAR) proteins, such as the overexpression of angiogenesis-related proteins like TF, VEGF, VEGF-R, and metalloproteinase 2 (MMP-2) [5,8,9]. Here, TF is linked to cancer.